• About us
  • Products
    • Mammowave
    • Brainwave
  • Projects
    • MammoWave – H2020
    • Rover H2020
    • MammoScreen – HORIZON
    • RadioSpin – H2020
  • News
  • Resources
    • Publications
    • Media
    • Awards
  • Contact us
  • Contact us
          • English
          • Italian
  • English
    • Italiano (Italian)

MammoWave, our X-rays free mammogram

To detect breast cancer when it can be cured

MAMMOWAVE

What is our X-rays free mammogram?

MammoWave is a revolutionary safe solution for the detection of breast lesions. Using microwave radiofrequency signals to perform imaging, its innovative technology is non-ionizing (free from X-rays), meaning there is no radiation risk.

Discover more
Play Video
BENEFITS

X-rays free mammogram benefits

MammoWave is the perfect solution for a more inclusive breast screening, enhancing breast cancer early detection

NO X-RAYS

MammoWave uses safe low-power (1 mW) radiofrequency signal in the microwave band (1-9 GHz), rather than dangerous X-rays.

ACCURATE

MammoWave provides breast images, highlighting eventual lesions with high sensitivity and specificity. Performances hold for dense breasts.

COMFORTABLE

MammoWave does not require any breast compression. A breast scan is completed whilst the person is in a horizontal face down position.

AI

Performances are augmented by dedicated Artificial Intelligence (AI) algorithms

FOR ALL WOMEN, ANY TIME

MammoWave is a novel, safe and accurate imaging device, which allows Hospitals and Clinics to promote a more inclusive breast examinations, also in young women

PATENTED AND CE MARKED DEVICE

MammoWave is a patented device, with patent granted in EU, US and China. MammoWave is a CE-marked medical device (class IIa).

CLINICAL TRIALS

MammoWave has been clinically validated in the context of a Feasibility Clinical Trials (completed in 2020) and a Multicenter International Trial (completed in 2021). Further Clinical Trials are ongoing

TOWARDS EARLY DETECTION

MammoWave can be used in all the asymptomatic population, without any restrictions such as age and frequency of use

Our Company

Pioneering Microwave Imaging

Ubt (Umbria Bioengineering Technologies) develops and commercialises a portfolio of innovative medical imaging devices based on cutting-edge microwaves technology instead of dangereous ionizing radiation. Ubt devices meet existing needs for safer imaging techniques providing patented, novel, cost-effective, accurate alternatives to current devices.

OUR PATH

Innovation in microwaves and imaging

UBT Srl is a Benefit Company based in Assisi (Italy) with a Subsidiary in London. Founded in 2015 as an academic Spin Off of the University of Perugia, it has been awarded numerous grants under Horizon 2020 (European Commission). UBT activated and sponsored Clinical Trials in prestigious Italian and European hospitals. UBT is ISO 13485 certified.

2012
The first prototype of MammoWave, the X-rays free mammogram, is constructed and patented (inventors: Gianluigi Tiberi and Giovanni Raspa)
2012-2014
Phantom experiments, in collaboration with the Department of Physics and Geology of the University of Perugia, Italy
2015
UBT was founded as an innovative biomedical Start Up. A few months after its establishment, UBT SRL becomes an academic Spin Off University of Perugia, Italy
2015
A second prototype is constructed, MammoWave II
2016
Clinical trials start at Perugia Hospital, Italy, using MammmoWave II
2017
Clinical trials start at Foligno hospital, Italy, using MammmoWave III
2017
DIGITEC SRL, leading company in the development of software capable of acquiring, processing and transferring medical images, becomes UBT partner
2017
UBT's MammoWave project wins an European H2020 grant in the SMEINST Phase 1 call
2018
A new prototype, MammoWave EU, is constructed as an upgrade of MammoWave III
2018
UBT's MammoWave project wins an European H2020 grant in the SMEINST Phase 2 call
2019
BrainWave, a new microwave imaging device for brain stroke classification, is constructed and tested on phantoms
2019
UBT installs a microwave imaging device at London South Bank University, UK, activating Industrial PhD and Post-PhD scholarships
2020
Registration of UBT UK Division, UBT subsidiary (company number: 13096679)
2020
MammoWave obtains the CE marking from MTIC InterCert Srl (Italy)
2021
UBT wins an European H2020 FET grant
2021
MammoWave obtains the ISO 13485 from MTIC InterCert Srl (Italy)
brain1
OTHER MICROWAVE IMAGING DEVICES

Brainwave

BrainWave is a new medical device using safe microwave imaging technology to provide stroke pre-hospital classification

Discover more
News

The latest from the UBT world

  • December 12, 2022

Kick-off Meeting MammoScreen

Read More
  • October 6, 2022

SIRM

Read More
  • August 20, 2022

MammoScreen Project

Read More
  • July 1, 2022

ECR 2022 VIENNA

Read More

INTERESTED IN OUR DEVICE FOR YOUR HOSPITAL OR YOUR CLINIC?

Do not hesitate to contact us. We will be happy to inform you about our innovative medical devices

Contact us

Useful Links

  • Home
  • News
  • Contact us
  • Privacy policy
  • Cookie Policy
  • Home
  • News
  • Contact us
  • Privacy policy
  • Cookie Policy
  • Home
  • News
  • Contact us
  • Privacy policy
  • Cookie Policy
  • Home
  • News
  • Contact us
  • Privacy policy
  • Cookie Policy
45055_st_francis_md

UBT Srl

Santa Maria della Spina Str., 25
06081 Rivotorto di Assisi (PG) Italy

VAT: 03434740548

Tel: +39 3490564302
gianluigi@ubt-tech.com (Scientific)
g.raspa@ubt-tech.com (Hardware)
s.tiberi@ubt-tech.com (Business)
amministrazione@ubt-tech.com (Administration)

london2

UBT UK Division

3rd Floor 207 Regent Street, London, W1B 3HH (Registered)
103 Borough Rd, London, SE1 0AA (Operational)

Company number 13096679

Tweets by UBTsrl
Linkedin Twitter Youtube

According to the Italian Ministry of Health guidelines of 28/03/2013, the information contained in this website is exclusively intended for professional operators.

© 2023UBT S.r.l. All Rights Reserved.